It's good to keep us updated instead of wondering where results are - good to hear recruitment continues and the evidence supports a phase III trial. This mean the drug is clearly marketable and now they are refining where it could sit in the market, it will be easy to attract some partners and a licensing agreement.
It's good to keep us updated instead of wondering where results...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $92.82M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 22.5¢ | $31.26K | 137.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 170045 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 25860 | 2 |
View Market Depth
| Last trade - 10.55am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 23.5¢ | 22.5¢ | 127389 | ||
| Last updated 11.47am 02/05/2024 ? | |||||
| PAA (ASX) Chart |